Neuro-Oncology News

Cancer death rates appeared higher in rural than urban areas despite lower overall cancer incidence in rural areas, according to data from the CDC published in Morbidity and Mortality Weekly Report.

The FDA granted 510(k) clearance to the Halcyon treatment system for use with image-guided volumetric intensity modulated radiotherapy, according to the device’s manufacturer.

The FDA cleared the expanded use of the DigniCap Cooling System to reduce hair loss during chemotherapy to include all patients with solid tumors.

CHICAGO — Convection-enhanced delivery of a radio-labeled monoclonal antibody to the brain stem appeared safe among a small cohort of children with nonprogressive diffuse intrinsic pontine glioma, according to results of a phase 1 clinical trial.

Life expectancy is up and tobacco use is down, but there are still several concerning health indicators in the CDC’s 40th annual report on long-term trends in health and health care delivery of the nation between 1975 and 2015 which was delivered from the Secretary of HHS to President Donald Trump and Congress.

Former Vice President Joe Biden and his wife, Jill Biden, PhD, launched the Biden Cancer Initiative today.

In recognition of Cancer Immunotherapy Month, Cancer Research Institute has organized a series of educational and social events designed to raise awareness regarding these treatment options.

The addition of high-dose vitamin C to standard chemotherapy or radiation appeared to effective and safe for patients with glioblastoma multiforme and non–small cell lung cancer, according to study results.

Hospital-based end-of-life care for elderly patients with malignant brain tumors is associated with up to $16,000 in expenses, according to a research letter published in JAMA Oncology.

The FDA approved aminolevulinic acid hydrochloride as an optical imaging agent indicated for patients with gliomas as an adjunct for the visualization of malignant tissue during surgery, according to the agent’s manufacturer.